Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Quiros PM"'
Autor:
Guo J; Wellcome Sanger Institute, Hinxton, UK.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK., Walter K; Wellcome Sanger Institute, Hinxton, UK., Quiros PM; Wellcome Sanger Institute, Hinxton, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Gu M; Wellcome Sanger Institute, Hinxton, UK., Baxter EJ; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain., Danesh J; Wellcome Sanger Institute, Hinxton, UK.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK., Di Angelantonio E; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK.; Fondazione Human Technopole, Milan, Italy., Roberts D; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.; NHS Blood and Transplant-Oxford Centre, John Radcliffe Hospital and Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK., Guglielmelli P; Department of Experimental and Clinical Medicine, Center for Research and Innovation of Myeloproliferative Neoplasms (CRIMM), AOU Careggi, University of Florence, Florence, Italy., Harrison CN; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Godfrey AL; Cambridge University Hospitals NHS Trust, Cambridge, UK., Green AR; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Vuckovic D; Wellcome Sanger Institute, Hinxton, UK.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.; Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, London, UK., Nangalia J; Wellcome Sanger Institute, Hinxton, UK. jn5@sanger.ac.uk.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk.; Cambridge University Hospitals NHS Trust, Cambridge, UK. jn5@sanger.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. jn5@sanger.ac.uk., Soranzo N; Wellcome Sanger Institute, Hinxton, UK. ns6@sanger.ac.uk.; National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK. ns6@sanger.ac.uk.; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK. ns6@sanger.ac.uk.; Fondazione Human Technopole, Milan, Italy. ns6@sanger.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. ns6@sanger.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2024 Feb; Vol. 56 (2), pp. 273-280. Date of Electronic Publication: 2024 Jan 17.
Autor:
Cheloor Kovilakam S; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Gu M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Dunn WG; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom., Marando L; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom., Barcena C; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Department of Biochemistry and Molecular Biology, Universidad de Oviedo, Oviedo, Spain., Nik-Zainal S; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Mohorianu I; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom., Kar SP; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; Section of Translational Epidemiology, Division of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Fabre MA; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom., Quiros PM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, University of Cambridge, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.
Publikováno v:
Blood [Blood] 2023 Oct 05; Vol. 142 (14), pp. 1185-1192.
Autor:
Gu M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Kovilakam SC; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Dunn WG; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Marando L; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Barcena C; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Biochemistry and Molecular Biology, Universidad de Oviedo, Oviedo, Spain., Mohorianu I; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Smith A; Epidemiology and Cancer Statistics Group, University of York, York, UK., Kar SP; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Section of Translational Epidemiology, Division of Population Health Sciences, Bristol, Medical School, University of Bristol, Bristol, UK.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Fabre MA; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gerstung M; Division of Artificial Intelligence in Oncology, DKFZ, Heidelberg, Germany., Cargo CA; Haematological Malignancy Diagnostic Service, St James's Hospital, Leeds, UK.; Department of Haematology, Leeds Teaching Hospitals, Leeds, UK., Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Quiros PM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.; Department of Haematology, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.; Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain. pmquiros@ispasturias.es., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@cam.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2023 Oct; Vol. 55 (10), pp. 1777.
Autor:
Gu M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Kovilakam SC; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Dunn WG; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Marando L; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Barcena C; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Biochemistry and Molecular Biology, Universidad de Oviedo, Oviedo, Spain., Mohorianu I; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Smith A; Epidemiology and Cancer Statistics Group, University of York, York, UK., Kar SP; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Section of Translational Epidemiology, Division of Population Health Sciences, Bristol, Medical School, University of Bristol, Bristol, UK.; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Fabre MA; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Gerstung M; Division of Artificial Intelligence in Oncology, DKFZ, Heidelberg, Germany., Cargo CA; Haematological Malignancy Diagnostic Service, St James's Hospital, Leeds, UK.; Department of Haematology, Leeds Teaching Hospitals, Leeds, UK., Malcovati L; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Department of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Quiros PM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.; Department of Haematology, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.; Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain. pmquiros@ispasturias.es., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK. gsv20@cam.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2023 Sep; Vol. 55 (9), pp. 1523-1530. Date of Electronic Publication: 2023 Aug 24.
Autor:
Quiros PM; Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, United Kingdom.; Department of Hematology, University of Cambridge, United Kingdom.; Department of Hematology, Cambridge University Hospitals NHS Trust, United Kingdom.
Publikováno v:
HemaSphere [Hemasphere] 2023 Aug 17; Vol. 7 (9), pp. e947. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Autor:
Zhou Y; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Shalhoub R; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD., Rogers SN; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Yu S; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD., Gu M; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Fabre MA; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Quiros PM; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Shin TH; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD.; Department of Laboratory Animal Medicine, College of Veterinary Medicine, Jeju National University, Jeju, Republic of Korea., Diangson A; Cancer Molecular Diagnostics Laboratory, University of Cambridge, Cambridge, UK., Deng W; Cancer Molecular Diagnostics Laboratory, University of Cambridge, Cambridge, UK., Anand S; Cancer Molecular Diagnostics Laboratory, University of Cambridge, Cambridge, UK., Lu W; East Genomic Laboratory Hub, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK., Cullen M; East Genomic Laboratory Hub, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK., Godfrey AL; Haematopathology and Oncology Diagnostics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Preller J; John Farman Intensive Care Unit, Cambridge University Hospital, Cambridge, UK., Hadjadj J; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris Cité University, Paris, France., Jouanguy E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University of Paris, Imagine Institute, Paris, France., Cobat A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University of Paris, Imagine Institute, Paris, France., Abel L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University of Paris, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY., Rieux-Laucat F; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université de Paris, Institut Imagine, INSERM UMR 1163, Paris, France., Terrier B; Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, APHP.CUP, Hôpital Cochin, Paris Cité University, Paris, France., Fischer A; Université de Paris, Institut Imagine, and Paediatric Immuno-Haematology and Rheumatology Department, Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.; Collège de France, Paris, France., Novik L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Gordon IJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Strom L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Gaudinski MR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Lisco A; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Sereti I; HIV Pathogenesis Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Gniadek TJ; Department of Pathology and Laboratory Medicine, NorthShore University Health System, Evanston, IL., Biondi A; Pediatric Department and Centro Tettamanti-European Reference Network PaedCan, EuroBloodNet, MetabERN-University of Milano-Bicocca-Fondazione MBBM-Ospedale San Gerardo, Monza, Italy., Bonfanti P; Department of Infectious Diseases, San Gerardo Hospital-University of Milano-Bicocca, Monza, Italy., Imberti L; CREA Laboratory (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy., Dalgard CL; Primer, Uniformed Services University of the Health Sciences, Bethesda, MD., Zhang Y; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.; National Institute of Allergy and Infectious Diseases Clinical Genomics Program, NIH, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Dobbs K; National Institute of Allergy and Infectious Diseases Clinical Genomics Program, NIH, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Su HC; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.; National Institute of Allergy and Infectious Diseases Clinical Genomics Program, NIH, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.; National Institute of Allergy and Infectious Diseases Clinical Genomics Program, NIH, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD., Wu CO; Office of Biostatistics Research, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD., Openshaw PJM; National Heart and Lung Institute, Imperial College London, Chelsea, London, UK., Semple MG; NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK., Mallat Z; Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UK.; INSERM U970, Paris Cardiovascular Research Center, Paris, France.; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Baillie K; Roslin Institute, University of Edinburgh, Edinburgh, UK.; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.; Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK., Dunbar CE; Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Publikováno v:
Blood [Blood] 2022 Oct 06; Vol. 140 (14), pp. 1650-1655.
Autor:
Kar SP; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. siddhartha.kar@bristol.ac.uk.; Section of Translational Epidemiology, Division of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK. siddhartha.kar@bristol.ac.uk., Quiros PM; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. pmquiros@ispasturias.es.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. pmquiros@ispasturias.es.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. pmquiros@ispasturias.es., Gu M; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Jiang T; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK., Mitchell J; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Langdon R; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.; Section of Translational Epidemiology, Division of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK., Iyer V; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Barcena C; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Vijayabaskar MS; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK., Fabre MA; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Carter P; Division of Cardiovascular Medicine, Department of Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia., Burgess S; BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Vassiliou GS; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. gsv20@cam.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. gsv20@cam.ac.uk.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. gsv20@cam.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2022 Aug; Vol. 54 (8), pp. 1155-1166. Date of Electronic Publication: 2022 Jul 14.
Autor:
Quiros PM; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain; and., Gu M; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Barcena C; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Iyer V; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom., Vassiliou GS; Wellcome-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, United Kingdom.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, United Kingdom.; Department of Haematology, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2409-2413.
Autor:
Pfannschmidt T; Institute of Botany, Plant Physiology, Leibniz University Hannover, Herrenhäuser Straße 2, 30419 Hannover, Germany., Terry MJ; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Van Aken O; Department of Biology, Lund University, Sölvegatan 35, 223 62 Lund, Sweden., Quiros PM; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Publikováno v:
Philosophical transactions of the Royal Society of London. Series B, Biological sciences [Philos Trans R Soc Lond B Biol Sci] 2020 Jun 22; Vol. 375 (1801), pp. 20190396. Date of Electronic Publication: 2020 May 04.
Autor:
Gu M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Zwiebel M; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; German Consortium for Translational Cancer Research (DKTK), Partnering Site, Munich, Germany., Ong SH; Cancer Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Boughton N; Core Software Services, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Nomdedeu J; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Basheer F; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK., Nannya Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Quiros PM; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Ogawa S; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Cazzola M; Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy., Rad R; German Consortium for Translational Cancer Research (DKTK), Partnering Site, Munich, Germany., Butler AP; Cancer Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, Cambridge, UK., Vijayabaskar MS; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK vm11@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK., Vassiliou GS; Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK gsv20@sanger.ac.uk.; Wellcome Trust-MRC Stem Cell Institute, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, UK.
Publikováno v:
Haematologica [Haematologica] 2020 Jun; Vol. 105 (6), pp. e290-e293. Date of Electronic Publication: 2019 Oct 24.